key: cord-0793425-gs0847v0
authors: Fagiani, Francesca; Catanzaro, Michele; Lanni, Cristina
title: Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2
date: 2020-08-25
journal: Signal Transduct Target Ther
DOI: 10.1038/s41392-020-00287-4
sha: 82982a7c987e2ef62bddfd43436c0ae2f6c1478f
doc_id: 793425
cord_uid: gs0847v0

nan

an example, despite SARS-CoV-2 and SARS-CoV display both sequential and structural similarities, diverse viral species-specific responses have been observed in patients. 5 Such evidence justifies the failures of the attempts to neutralize SARS-CoV-2 by using previously isolated SARS-CoV antibodies. 5 Moreover, the authors provided evidence that CC12.1 presents immunoglobulin kappa variable1-9 (IGKV1-9) and CCL12.3 IGKV3-20, thereby suggesting that IGHV3-53 can pair with different light chains. Such finding indicates that the identity of the heavy chain, instead of that of the light-chain, might be critical for targeting ACE2 binding site in SARS-CoV-2 RBD.

Furthermore, the complementarity-determining regions (CDRs) of IGHV3-53 were structurally analyzed. Based on structural analysis, the presence of two structural motifs, the NY motif in the CDR H1 and an SGGS motif in the CDR H2, as well as the short length of CDR H3, appear fundamental for the binding to the RBD. CDR H1 and H2 of CC12.1 and CC12.3 antibodies have been found to stabilize the CDR conformation with the surrounding framework and to establish hydrogen bonds with the carbonyl backbone of key amino acids in the RBD. While high similarity in the interaction modes between SARS-CoV-2 RBD and CDR H1 and H2 loops has been found, significant differences in the CDR H3 sequence and conformations have been observed when comparing two antibodies. As an example, while CDR H3 of CC12.2 has been found to establish a hydrogen bond with RDB Y453, CDR H3 of CC12.3 has been observed not to form it. Notably, an interesting feature of CDR H3 region of IGHV3-53-encoded antibodies is its short length. Accordingly, CC12.1 and CC12.3 have a CDR H3 consisting of nine amino acids in lengths. This structural feature may rely on the fact that the epitopes of IGHV3-53 antibodies are relatively flat and present a small pocket to insert the CDR H3 loop. Hence, longer CDR H3 regions might not be accommodated in IGHV3-53-encoded antibodies.

In sum, based on this structural characterization, Yuan and collaborators shed lights on some key molecular features (illustrated in Fig. 1 ) contributing to an effective antibody response against SARS-CoV-2 infection, demonstrating that IGHV3-53 provides a versatile framework to target the ACE2 binding site in SARS-CoV-2 RBD.

In conclusion, understanding of IGHV3-53-encoded antibodies and, in general, of anti-SARS-CoV-2 neutralizing antibodies, produced by infected donors, is required to generate immunogens that optimally present neutralizing epitopes to the immune system. Such approach may further open new horizons toward the identification of multiple functional antibodies, derived from several donors and directed toward single epitopes regions in order to combine sites of different shapes recognizing the critical regions, thereby capturing the biological diversity of antibody response. 2 The characterization by Yuan et al. may also allow to create anti-SARS-CoV-2 antibody templates for immunogens design, thus greatly improving the sophistication in the design of immunogens and in immunization strategies. 

Structural basis of a shared antibody response to SARS-CoV-2

What are the most powerful immunogen design vaccine strategies? Reverse vaccinology 2.0 shows great promise

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source

This work has been supported by the University of Pavia (Grants from FR&G 2019, Fondo Ricerca & Giovani, to C.L.).

Competing interests: The authors declare no competing interests.Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons. org/licenses/by/4.0/.